Salvage autologous hematopoietic cell transplant should be considered for patients with multiple myeloma who have relapsed after initial transplant, according to the results of a restrospective analysis.

The study included data from 44 patients with multiple myeloma who had undergone a second salvage autologous hematopoietic cell transplant between 1992 to 2008.

JUMP TO STORY